Hammerbeck; David M.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Hammerbeck; David M..The latest application filed is for "therapeutic combinations and methods including irm compounds".

Company Profile

0.8.10

Hammerbeck; David M. - Houlton WI

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Therapeutic Combinations And Methods Including Irm Compounds App 20150110784 - Tomai; Mark A. ; et al.	2015-04-23
Therapeutic combinations and methods including IRM compounds Grant 8,940,755 - Tomai , et al. January 27, 2	2015-01-27
Formulations containing an immune response modifier Grant 8,221,771 - Hammerbeck , et al. July 17, 2	2012-07-17
Prophylactic treatment of UV-induced epidermal neoplasia Grant 8,110,582 - Egging , et al. February 7, 2	2012-02-07
Formulations Containing an Immune Response Modifier App 20070292456 - Hammerbeck; David M. ; et al.	2007-12-20
Therapeutic combinations and methods including IRM compounds App 20050226878 - Tomai, Mark A. ; et al.	2005-10-13
Therapeutic combinations and methods including IRM compounds App 20050171072 - Tomai, Mark A. ; et al.	2005-08-04
Immunomodulatory combinations App 20050158325 - Hammerbeck, David M. ; et al.	2005-07-21
Infection prophylaxis using immune response modifier compounds App 20050070460 - Hammerbeck, David M. ; et al.	2005-03-31
Immune response modifier compounds for treatment of TH2 mediated and related diseases App 20040242620 - Tomai, Mark A. ; et al.	2004-12-02
Prophylactic treatment of UV-induced epidermal neoplasia App 20040175336 - Egging, Elaine A. ; et al.	2004-09-09
Immune response modifier compounds for treatment of TH2 mediated and related diseases Grant 6,696,076 - Tomai , et al. February 24, 2	2004-02-24
Immune Response Modifier Compounds For Treatment Of Th2 Mediated And Related Diseases App 20030206868 - Tomai, Mark A. ; et al.	2003-11-06
Immune response modifier compounds for treatment of TH2 mediated and related diseases Grant 6,610,319 - Tomai , et al. August 26, 2	2003-08-26
Immune response modifier compounds for treatment of TH2 mediated and related diseases App 20020041887 - Tomai, Mark A. ; et al.	2002-04-11
Immine response modifier compounds for treatment of TH2 mediated and related diseases Grant 6,200,592 - Tomai , et al. March 13, 2	2001-03-13
Immune response modifier compounds for treatment of TH2 mediated and related diseases Grant 6,039,969 - Tomai , et al. March 21, 2	2000-03-21

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.